🇺🇸
– Following its Parkinson’s disease program, iRegene advances another off-the-shelf cell therapy into clinical development in the U.S. and China. CHENGDU, China, Sept. 29, 2026 /PRNewswire/ — iRegene Therapeutics Co., Ltd. (“iRegene” or the “Company”), a biotechnology company pioneering…
Source: prnewswire
Country: United States